MG

Mathews George

Active Director Director DIN 01838757
DIN 01838757 First appointment Aug 2008 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Mathews George

Data last updated:

Mathews George is a Director at Cnidus Pharma Private Limited (since 2008). The company operates in Chemicals.

DIN 01838757
Primary Designation Director
Industry Chemicals
First Appointment 01 Aug 2008
Oldest Company Age 20 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cnidus Pharma Private Limited U24232KL2006PTC019188
Director01 Aug 20082006Active

Directorship timeline

Open interactive timeline →
Cnidus Pharma Private Limited
Premium access

Shareholding and investment profile for Mathews George

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mathews George

Mathews George currently holds 1 directorship: Cnidus Pharma Private Limited (Director, since 01 Aug 2008).

Mathews George was first appointed on 01 Aug 2008 as Director at Cnidus Pharma Private Limited.

The current boards of Mathews George's companies include Chacko Mathai Mattathil (Cnidus Pharma Private Limited), Francis Thomas (Cnidus Pharma Private Limited), George Jacob (Cnidus Pharma Private Limited), George John (Cnidus Pharma Private Limited), George Joseph Mookken (Cnidus Pharma Private Limited), Jeena George (Cnidus Pharma Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available